MiMedx Group (NASDAQ: MDXG) reported Q2 EPS of $0.10, $0.05 better than the analyst estimate of $0.05. Revenue for the quarter came in at $98.61 million versus the consensus estimate of $90.62 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.